August 20, 2021 Comments Off on New patent for Astrazeneca Ab drug BYDUREON BCISE Posted in: Patent Added Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are fifteen…
The post New patent for Astrazeneca Ab drug BYDUREON BCISE appeared …
August 20, 2021 Comments Off on New patent for Astrazeneca Ab drug BYDUREON PEN Posted in: Patent Added Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-two…
The post New patent for Astrazeneca Ab drug BYDUREON PEN appeared fir…
